Bringing new cell and gene therapies to life.
First-time inventors of biomedical technology face huge obstacles bringing their therapies to market.
Many simply lack the experience to start a company, court investors, gain regulatory experience, and continue to focus on the science.
Vida Biomedical’s mission is to help biomedical innovators bring their discoveries from the laboratory to the clinic.
You focus on the science. We take care of everything else.
Vida provides a full-range of biomedical and commercial capabilities to facilitate cell or gene therapy development through Phase I clinical trials.
Partnering with a university-affiliated global leader in HLA and stem cell research, Vida provides inventors:
Complete laboratory support
Day-to-day corporate operations management
Funding
Practical guidance for securing patents, licensing, and FDA approval
We bridge “The Valley of Death” in medical therapy development.
During the Pre-Clinical and Phase I periods, inventors have few options for fundraising and gaining critically needed regulatory expertise.
The risks and pitfalls that inventors face during this “Valley of Death” include:
Significant financial risks and challenges for those who self-finance
High equity dilution due to unfavorable investment terms
Lack of knowledge about the regulatory environment
Tremendous time demands that detract from professional and entrepreneurial growth
Vida enables inventors to realize the full potential of their discoveries.
Unlike a typical VC, Vida allows inventors to retain more of their equity and control over the decision-making process.
At the same time, Vida manages the day-to-day needs of the company, freeing inventors to do what they do best: create.
Market and Strategy Development
Startup Capital and Investor Relations
Legal and IP Expertise
Regulatory and Quality Oversight
Supply Chain Management
Finance and Accounting
Why partner with Vida?
We provide startup capital and keep startup costs much lower than what most inventors encounter.
Our executive team works closely with inventors to guide promising ideas from the patent stage to IPO or acquisition.
How Vida & Inventors Work Together.
Vida is a venture builder.
We work with inventors who have promising therapies and established IP.
For each inventor partner therapy, Vida establishes a separate company, startup investment, and provides:
A proven, cost-efficient path for commercialization
Regulatory support services
Licensing fees for the IP or stem cell therapy
A contract for IND submission and clinical trials
Increased equity vs. traditional VCs
Meet our team.
Richard Freed, CEO
Prior to co-founding Vida Biomedical, Richard spent 10 years in DuPont’s Sustainable Solutions and Industrial Biosciences divisions, where he worked in biotech commercialization, technology licensing, and new venture launches. He holds an MBA from the University of North Carolina.
Brian Freed PhD. / Chief Science Officer
Dr. Freed is the Executive Director of the University of Colorado’s ClinImmune Labs and inventor of a breakthrough HLA gene editing therapy for rheumatoid arthritis that has been licensed into Vida’s first portfolio company; RheumaGen.
Brian Hart, Chief Operating Officer
Brian spent 7 years with Paul Weiss LLP, gaining valuable experience with intellectual property and pharmaceutical litigation. He is as a former Advisory Neighborhood Commissioner in Washington, D.C. and holds a JD from Georgetown University.
Ryan Hart, Chief Legal Officer
Ryan is a former federal and state prosecutor and of-counsel attorney with Dickinson Wright PLLC Washington D.C. office. He holds a JD from Georgetown Law School and specializes in business law, commercial litigation, and internal investigations.
Arman Tan, VP Marketing
Arman has over 20 years in management consulting, 14 of which he spent advising senior leaders at DuPont in corporate strategy, new business ventures, and M&A. He holds an MBA from Stanford University.
Get in touch.
We’re excited to hear about promising new therapies and welcome all serious inquiries. Please use the adjacent form to tell us a little about your company and we will contact you shortly with next steps.